Your browser doesn't support javascript.
Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China.
Yang, Yunfan; Zhang, Yanli; Jiang, Qian; Meng, Li; Li, Weiming; Liu, Bingcheng; Liu, Xiaoli; Zhou, Li; Liang, Rong; Zhu, Xiaojian; Kuang, Pu; Lin, Ting; Zhu, Huanling.
  • Yang Y; Department of Hematology, Institute of Hematology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
  • Zhang Y; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Provincial Tumor Hospital, Zhengzhou, Henan 450000, China.
  • Jiang Q; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100000, China.
  • Meng L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China.
  • Li W; Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China.
  • Liu B; Department of Leukemia, National Clinical Research Center for Blood Disease, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin 300020, China.
  • Liu X; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510000, China.
  • Zhou L; Department of Leukemia, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 201100, China.
  • Liang R; Department of Hematology, Xijing Hospital, Air Force Medical University of PLA, Xi'an, Shaanxi 710000, China.
  • Zhu X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China.
  • NaXu; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510000, China.
  • Kuang P; Department of Hematology, Institute of Hematology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
  • Lin T; Department of Hematology, Institute of Hematology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
  • Zhu H; Department of Hematology, Institute of Hematology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Chin Med J (Engl) ; 135(12): 1498-1499, 2022 06 20.
Article in English | MEDLINE | ID: covidwho-2037561
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / COVID-19 Vaccines / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Chin Med J (Engl) Year: 2022 Document Type: Article Affiliation country: CM9.0000000000001899

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / COVID-19 Vaccines / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Chin Med J (Engl) Year: 2022 Document Type: Article Affiliation country: CM9.0000000000001899